Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Stephanie Wehrstedt"'
Autor:
Dennis Christensen, Kathrin Kennerknecht, Daniel Mayer, Steffen Stenger, Mark Grieshober, Stephanie Wehrstedt, Florian Löffler, Gabriel K. Pedersen, Reiner Noschka
Publikováno v:
Medical Microbiology and Immunology. 209:163-176
A major roadblock in the development of novel vaccines is the formulation and delivery of the antigen. Liposomes composed of a dimethyldioctadecylammonium (DDA) backbone and the adjuvant trehalose-6-6-dibehenate (TDB, termed “cationic adjuvant form
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb292258a466a43a8a5bce0a99b429f2
https://doi.org/10.1007/s00430-020-00657-3
https://doi.org/10.1007/s00430-020-00657-3
Autor:
Kathrin, Kennerknecht, Reiner, Noschka, Florian, Löffler, Stephanie, Wehrstedt, Gabriel Kristian, Pedersen, Daniel, Mayer, Mark, Grieshober, Dennis, Christensen, Steffen, Stenger
Publikováno v:
Medical Microbiology and Immunology
A major roadblock in the development of novel vaccines is the formulation and delivery of the antigen. Liposomes composed of a dimethyldioctadecylammonium (DDA) backbone and the adjuvant trehalose-6-6-dibehenate (TDB, termed “cationic adjuvant form
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a7455d58a6d522694d748c96ea444b69
https://pubmed.ncbi.nlm.nih.gov/32020284
https://pubmed.ncbi.nlm.nih.gov/32020284
Autor:
Stephanie Wehrstedt, Steffen Stenger, Heiko Bruns, Mark Grieshober, Daniel Mayer, Andreas Zimmermann, Jan Kubis
Publikováno v:
European journal of immunology. 48(11)
Tyrosine kinases are checkpoints for multiple cellular pathways and dysregulation induces malignancies, most notably chronic myeloid leukemia (CML). Inhibition of Abl-tyrosine kinases has evolved as a new concept for the treatment of CML and other ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ee9ce15c3e567200b6bcd5eb9e64464
https://pubmed.ncbi.nlm.nih.gov/30242834
https://pubmed.ncbi.nlm.nih.gov/30242834